BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-...

June 06, 2022 | News

Hanmi Fine Chemical Launches 'high-tech CDMO' Business

10 billion KRW invested in Hanmi Fine Chemical facility expansion Hanmi Fine Chemical (hereinafter Hanmi FC) a subsidiary of Hanmi Pharmaceutic...

May 23, 2022 | News

Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award

Company efforts balance strategic growth and sustainability A successful record of meeting increasing market dynamics Ongoing commitment to fulfilling ...

May 19, 2022 | News

‘Don’t be left short-changed post approval – plan in change orders early for accelerated pathways’

A post approval change order is often necessary, but innovators should plan and prepare for this pre-approval. Planning alongside outsourcing par...

May 19, 2022 | News

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets

Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of ...

May 11, 2022 | News

Biomerics Announces Image Guided Intervention (IGI) Division

The goal of image-guided intervention systems is to increase the clinician's spatial navigation abilities while reducing the mental burden associated with ...

May 03, 2022 | News

Samsung Biologics Reports First Quarter 2022 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results for t...

April 28, 2022 | News

WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability

One example of WuXi Biologics' contribution to society is its rapid, robust pandemic response -- enabling nearly 30 Investigational New Drug Applications (...

April 28, 2022 | News

Samsung Biologics completes full acquisition of Samsung Bioepis

Samsung Biologics (KRX: 207940.KS) announced today that it has completed the purchase of Biogen's stake in the Samsung Bioepis joint venture for USD $...

April 21, 2022 | News

WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC

This marks the second consecutive year that WuXi Bio has received this award from IMAPAC, a leading consulting firm in biopharmaceutical industry. S...

April 18, 2022 | News

Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza

Merck to become first company to offer a fully integrated ecosystem for advanced process technologies Brings biopharmaceutical industry closer to digita...

April 14, 2022 | News

AGC to Expand Synthetic Pharmaceutical Production Base in Spain

A new building with a total floor area of 7,500 m2 will be constructed on the company's site, increasing the current production capacity by 30%. ...

April 11, 2022 | News

CDMO's Shifting Focus to Meet Future Demand

Transformational forces are influencing the global contract development and manufacturing organization (CDMO) market's growth. Disruptive, innovative busin...

April 08, 2022 | News

GenScript Receives "Best Contract Development and Manufacturing Organization Award" For the Third Time in a Row

This marks the third consecutive year of GenScript bagging the same award in Asia Pacific region. The award also follows GenScript's re...

March 31, 2022 | News

Stay Connected